31 /100
MEDIUM RISK
Score updated May 30, 2026

CMCAW — Piermont Valley Acquisition Corp Dilution Risk Tracker

Track CMCAW dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CMCAW — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
10
📊 Float Risk
40
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CMCAW.
🔔 Track CMCAW — Get forecast alerts →

💹 Market Data

Market CapN/A
Shares OutstandingN/A
Float204.4K
Cash$53.2K
Debt$710.4K
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest395
Days to Cover1.0
% of Float0.2%
FINRA data as of Mar 31, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2024
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track CMCAW Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CMCAW — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for CMCAW
📊 CMCAW FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CMCAW Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.